Drug Patents owned by Angelini Pharma

1. Drug name - OLEPTRO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8133893 ANGELINI PHARMA Trazodone and trazodone hydrochloride in purified form
Mar, 2029

(6 years from now)

CN101772490B ANGELINI PHARMA Purification Trazodone And Trazodone Hydrochloride Form
Jul, 2028

(5 years from now)

CN101772490A ANGELINI PHARMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

IN201001179P4 ANGELINI PHARMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

IN285451B ANGELINI PHARMA A Process Of Production Of Purified Form Of Trazodone And Trazodone Hydrochloride
Jul, 2028

(5 years from now)

EP2178850A1 ANGELINI PHARMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

EP2178850B1 ANGELINI PHARMA Trazodone And Trazodone Hydrochloride In Purified Form
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7829120 ANGELINI PHARMA Trazodone composition for once a day administration Mar, 2027

(4 years from now)

Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient

Treatment: Method of treating depression

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
150MG TABLET, EXTENDED RELEASE;ORAL Discontinued
300MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.